Technical Analysis for TRML - Tourmaline Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 23.52 | -2.00% | -0.48 |
TRML closed up 2.13 percent on Wednesday, November 20, 2024, on 63 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | -2.00% | |
| Lower Bollinger Band Walk | Weakness | -2.00% | |
| Lower Bollinger Band Touch | Weakness | -2.00% | |
| Oversold Stochastic | Weakness | -2.00% | |
| MACD Bearish Centerline Cross | Bearish | 0.09% | |
| Lower Bollinger Band Walk | Weakness | 0.09% | |
| Below Lower BB | Weakness | 0.09% | |
| Down 3 Days in a Row | Weakness | 0.09% | |
| Gapped Down | Weakness | 0.09% | |
| Lower Bollinger Band Touch | Weakness | 0.09% |
| Alert | Time |
|---|---|
| Down 5% | about 2 hours ago |
| 60 Minute Opening Range Breakdown | about 3 hours ago |
| Down 3% | about 3 hours ago |
| Fell Below Lower Bollinger Band | about 3 hours ago |
| Fell Below Previous Day's Low | about 3 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Medication Thyroid Eye Disease Atherosclerosis Immune Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Medication Thyroid Eye Disease Atherosclerosis Immune Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 48.31 |
| 52 Week Low | 12.12 |
| Average Volume | 243,640 |
| 200-Day Moving Average | 22.05 |
| 50-Day Moving Average | 25.63 |
| 20-Day Moving Average | 26.47 |
| 10-Day Moving Average | 26.14 |
| Average True Range | 1.67 |
| RSI (14) | 40.12 |
| ADX | 24.1 |
| +DI | 13.19 |
| -DI | 26.31 |
| Chandelier Exit (Long, 3 ATRs) | 24.59 |
| Chandelier Exit (Short, 3 ATRs) | 28.26 |
| Upper Bollinger Bands | 29.10 |
| Lower Bollinger Band | 23.84 |
| Percent B (%b) | 0.03 |
| BandWidth | 19.88 |
| MACD Line | -0.30 |
| MACD Signal Line | 0.26 |
| MACD Histogram | -0.5553 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 25.95 | ||||
| Resistance 3 (R3) | 25.92 | 25.23 | 25.63 | ||
| Resistance 2 (R2) | 25.23 | 24.74 | 25.25 | 25.52 | |
| Resistance 1 (R1) | 24.62 | 24.43 | 24.93 | 24.65 | 25.41 |
| Pivot Point | 23.93 | 23.93 | 24.09 | 23.95 | 23.93 |
| Support 1 (S1) | 23.32 | 23.44 | 23.63 | 23.35 | 22.59 |
| Support 2 (S2) | 22.63 | 23.13 | 22.65 | 22.48 | |
| Support 3 (S3) | 22.02 | 22.63 | 22.38 | ||
| Support 4 (S4) | 22.05 |
